SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-022188
Filing Date
2024-03-13
Accepted
2024-03-13 16:31:49
Documents
15
Period of Report
2024-03-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0201602-8k_enzobio.htm   iXBRL 8-K 22689
2 PRESS RELEASE DATED MARCH 13, 2024 ea020160202ex99-1_enzobio.htm EX-99.1 121924
  Complete submission text file 0001213900-24-022188.txt   326452

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE enz-20240313.xsd EX-101.SCH 3000
4 XBRL LABEL FILE enz-20240313_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE enz-20240313_pre.xml EX-101.PRE 22350
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0201602-8k_enzobio_htm.xml XML 3497
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-09974 | Film No.: 24746399
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)